MEXICO Town (Reuters) – Mexican health authorities will make a determination this week on no matter if to authorize Russia’s Sputnik V COVID-19 vaccine right after finding obtain to details on it, Deputy Health Minister Hugo Lopez-Gatell claimed on Tuesday.
Lopez-Gatell claimed President Andres Manuel Lopez Obrador experienced instructed authorities to “proceed speedily” with the course of action.
“The file has been beneath overview due to the fact the weekend by (health and fitness regulator) COFEPRIS and extremely quickly there will be a conclusion regarding the authorization for crisis use, as happened with the other two vaccines,” he mentioned at a normal authorities news meeting.
He later claimed COFEPRIS was anticipated to make a final decision this 7 days on authorization for unexpected emergency use in Mexico.
Lopez-Gatell, Mexico’s coronavirus czar, said on Monday night that Mexico was thinking about acquiring 24 million doses of Sputnik V.
Mexico has presently licensed the vaccines created by Pfizer Inc with BioNTech SE and AstraZeneca Plc.
Lopez-Gatell claimed he satisfied with Russian officials to go over the vaccine in the course of a trip very last week to Argentina, whose governing administration has began rolling out Sputnik V to health workers.
Mexican officials experienced obtain to “the entire scientific and technological file” on the Russian vaccine though in Argentina, together with benefits of its Period III scientific trials. Previously, Mexico had problems obtaining information about Sputnik V, prompting protection fears, Lopez-Gatell added.
“It’s a vaccine that has a capacity and efficacy identical to all those of the other vaccines that have been approved,” he claimed.
Whilst the Russian Immediate Investment decision Fund (RDIF), which has funded Sputnik V, has offers with many international locations to source hundreds of thousands of doses, only about 1.5 million doses of the vaccine have rolled out domestically.
The RDIF has mentioned it options to depend on manufacturing partners in China, India, South Korea and in other places to satisfy its main global source discounts.
A shipment of practically 440,000 doses of Pfizer’s vaccine arrived in Mexico on Tuesday, the largest consignment yet to get to the region and a vital step toward the government’s purpose of concluding the vaccination of overall health staff this month.
Mexico could in February start receiving batches of a vaccine designed by Chinese company CanSino Biologics, Lopez-Gatell explained.
Reporting by Dave Graham and Raul Cortes more reporting by Polina Inanova in Moscow and Anthony Esposito in Mexico Town producing by Cassandra Garrison Enhancing by Andrew Heavens, Alex Richardson and Giles Elgood